India is leading the race among countries for creating an effective vaccine for the deadly and inevitable SARS-Cov-2. Whether or not India will be able to manufacture enough doses is the concern at the moment. The real India is in its rural areas and to distribute vaccines there is a logistical challenge that needs to be addressed with patience. There are about 230 programmes working on the vaccine and 130 companies are already on their advanced stage out of which 10 have already opted for clinical trials.
Several vaccine manufacturing companies in India already have agreements for manufacturing any effective immunization or vaccine that is in the making or being tested and prove to be effective. Not only can we make vaccines we have developed, but also similar solutions other countries are working on. “Without India, there won’t be enough vaccines to save the world.” said Peter Piot, director of the London School of Hygiene and Tropical Medicine in an online vaccine symposium organized by the Indian government in July.
Sahil Deo, co-founder of India’s CPC Analytics in Pune that is studying vaccine distribution, earlier this month, said that Indian drug companies are major manufacturers of vaccines distributed worldwide, particularly those for low-income countries, supplying more than 60% of vaccines supplied to the developing world. Because of this, they are likely to gain early access to any COVID-19 vaccine that works.
As India is the greatest manufacturer of the vaccine, it could be useful for the World. At the UNGA, Prime Minister Narendra Modi, in his speech, said “As the largest vaccine-producing country of the world, I want to give one more assurance to the global community today. India’s vaccine production and delivery capacity will be used to help all humanity in fighting this crisis.”
”India’s vaccine production and capacity will help the world overcome this pandemic. India sent medical supplies to over 150 countries during the coronavirus crisis.” he continued. He also mentioned that India was marching ahead with Phase-3 clinical trials – the large-scale trials considered the gold standard for determining safety and efficacy – and would help all countries enhance their cold chain and storage capacities for the delivery of vaccines. Modiji did not hold back after promising to support the world in this pandemic and made an on-paint statement and asked, “Till when do we have to wait? Till when will India be kept away from the UN’s decision-making process?”